Harrow Health, Inc. (HROW)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$40.85
+6.17%
Mkt Cap $1.40B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (13 analysts)
$75.67
Range $63.00 – $94.00
Implied Upside
+85.2%
Consensus $75.67 vs current $40.85